Multimodal Resin Purification of Factor VIII
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying recombinant Factor VIII are inefficient and often result in contamination, require multiple steps, and can destabilize the protein, making it challenging to achieve high purity and activity in large-volume production.
Innovation Solution
A single-step method using multimodal chromatography with resins containing hydrophobic and negatively charged ligands, employing an elution buffer with high salt and ethylene glycol concentrations, to capture and purify Factor VIII, reducing volume and increasing specific activity while stabilizing the protein.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional purification methods (immunoaffinity or ion exchange chromatography) are used, then Factor VIII can be purified, but the process requires multiple steps and results in contamination or protein destabilization
Solution Approach 1:
The patent combines multiple purification functions (capture, concentration, and purification) into a single chromatography step using multimodal resin. The resin integrates hydrophobic interaction, ion exchange, and affinity ligands, allowing simultaneous removal of contaminants including DNA, HCP, and viruses while concentrating the protein, thereby reducing multiple traditional steps into one efficient process
Solution Approach 2:
The patent employs multimodal resin as a composite material that incorporates multiple functional ligands (hydrophobic groups, charged groups, and affinity ligands) within a single stationary phase. This composite structure enables the resin to perform multiple purification mechanisms simultaneously, achieving high purity in a single step without requiring sequential traditional purification methods
2Manufacturing precision
If traditional purification methods are used, then Factor VIII can be purified, but the protein activity is lost or the protein is denatured
Solution Approach 1:
The patent utilizes controlled changes in buffer parameters (salt concentration, pH, and organic solvent content) during the elution phase to release the purified Factor VIII from the multimodal resin. By carefully adjusting these parameters, the method achieves high purity while maintaining protein activity, avoiding the denaturing conditions that occur in traditional methods
3Object-affected harmful factors
If viral inactivation methods (chemical, irradiation, or thermal) are applied, then viruses are inactivated, but the protein is denatured or requires additional separation steps
Solution Approach 1:
The patent extracts and removes viruses and viral contaminants during the chromatography purification process itself, utilizing the multimodal resin's ability to selectively bind and retain viral particles while allowing Factor VIII to pass through or be eluted separately. This eliminates the need for subsequent viral inactivation steps that could denature the protein
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves a 250-fold volume reduction and a 30-100-fold purification factor, providing a highly concentrated and stable Factor VIII solution with minimal loss of activity, even after repeated freeze/thaw cycles, thus overcoming the inefficiencies of traditional purification methods.
Implementation Method 1
contacting the Factor VIII protein with a multimodal or mixed mode resin containing ligands which comprise a hydrophobic part and a negatively charged part
Implementation Method 2
The protein of interest is bound to the resin and specifically eluted from the resin
Implementation Method 3
eluting the Factor VIII protein with an elution buffer containing at least 1.5 M salt and at least 40% (w/v) of ethylene glycol, propylene glycol, or a mixture thereof
Implementation Method 4
eluting the Factor VIII protein with an elution buffer containing at least 40% (w/v) of ethylene glycol, propylene glycol, or a mixture thereof
Data Source
AI summary
A method for purifying a recombinant protein using a multimodal or mixed mode resin containing ligands which comprise a hydrophobic part and a negatively charged part is described. The invention is advantageous in that it is a single step chromatographic process which does not require adjustment of pH or conductivity during loading step and results in high yield and potency. The process is used for the purification of recombinant compositions of coagulation factor, particularly recombinant Factor VIII.